209 related articles for article (PubMed ID: 32964981)
1. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
Li HP; Yang TZ; Wei L; Ge YF; Meng QS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
[TBL] [Abstract][Full Text] [Related]
2. Linc00324 promotes the progression of papillary thyroid cancer via regulating Notch signaling pathway.
Wan JF; Wan JY; Dong C; Li L
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6818-6824. PubMed ID: 32633374
[TBL] [Abstract][Full Text] [Related]
3. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.
Gao P; Jiao H; Zhe L; Cui J
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
Xiao X; Li L; Cui JC; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
[TBL] [Abstract][Full Text] [Related]
7. Promoting effect of PAX5-activated lncRNA UASR1 on growth of colorectal cancer by regulating the mTOR pathway.
Wang W; Wang Z; Wang H; Li X; Wang HT
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2986-2993. PubMed ID: 32271416
[TBL] [Abstract][Full Text] [Related]
8. LINC01535 promotes proliferation and inhibits apoptosis in esophageal squamous cell cancer by activating the JAK/STAT3 pathway.
Fang Y; Zhang S; Yin J; Shen YX; Wang H; Chen XS; Tang H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3694-3700. PubMed ID: 32329845
[TBL] [Abstract][Full Text] [Related]
9. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Guo L; Fang L; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
[TBL] [Abstract][Full Text] [Related]
11. SOX2-induced upregulation of lncRNA LINC01510 promotes papillary thyroid carcinoma progression by modulating miR-335/SHH and activating Hedgehog pathway.
Li Q; Wang XJ; Jin JH
Biochem Biophys Res Commun; 2019 Dec; 520(2):277-283. PubMed ID: 31590919
[TBL] [Abstract][Full Text] [Related]
12. C-MYC-induced upregulation of LINC01503 promotes progression of non-small cell lung cancer.
Zhang ML; Zhao TT; Du WW; Yang ZF; Peng W; Cui ZJ
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11120-11127. PubMed ID: 33215429
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
14. UCA1 promotes papillary thyroid carcinoma development by stimulating cell proliferation via Wnt pathway.
Lu HW; Liu XD
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5576-5582. PubMed ID: 30229831
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
Zhao YL; Yuan BQ; Shen GS
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
[TBL] [Abstract][Full Text] [Related]
16. MiR-200c promotes proliferation of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
Ren ZF; Du MF; Fu H; Liu J; Xia FY; Du HN; Liu N
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5512-5518. PubMed ID: 32495886
[TBL] [Abstract][Full Text] [Related]
17. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
Zhao M; Yang F; Sang C; Yan C; Wang Z
J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of LINC00346 inhibits proliferation of non-small cell lung cancer cells through mediating JAK-STAT3 signaling pathway.
Wang F; Chen JG; Wang LL; Yan ZZ; Chen SP; Wang XG
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5135-5142. PubMed ID: 29228425
[TBL] [Abstract][Full Text] [Related]
20. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]